Literature DB >> 18097042

Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors.

Alina I Marusina1, Steven J Burgess, Ishani Pathmanathan, Francisco Borrego, John E Coligan.   

Abstract

Human NKG2D/DAP10 is an activation receptor expressed by NK and subsets of T cells, whose ligands include MHC class I chain-related (MIC) protein A and protein B and UL16-binding proteins that are often up-regulated by stress or pathological conditions. DAP10 is required for NKG2D/DAP10 cell surface expression and signaling capacity. Little is known about the mechanisms that regulate DAP10 gene expression. We describe the existence of multiple transcriptional start sites upstream of DAP10 exon 1 and identify the location of the basic promoter upstream of these starting sites. The promoter is active in NK and CD8+ T cells, but not in CD4+ T cells. We demonstrate TCR-mediated up-regulation of DAP10 transcription and found that a 40 bp region within the DAP10 promoter, containing an Ap-1 binding site, is largely responsible for this increased transcription. Using pull-down and chromatin immunoprecipitation assays, we show that the DAP10 promoter interacts with Ap-1 transcription factors in primary CD8+ T and NK cells in vitro and in vivo. Overexpression of c-Jun or c-Fos in NK and T cells led to enhanced DAP10 promoter activity and DAP10 protein expression. Taken together, our data indicate that Ap-1 is an important transcription factor for regulating DAP10 gene expression in human NK and T cells, and that Ap-1 plays a key role in the transactivation of DAP10 promoter following TCR stimulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097042     DOI: 10.4049/jimmunol.180.1.409

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1.

Authors:  Jiuyu Gong; Rongrong Liu; Ran Zhuang; Yun Zhang; Liang Fang; Zhuwei Xu; Liang Jin; Tao Wang; Chaojun Song; Kun Yang; Yuying Wei; Angang Yang; Boquan Jin; Lihua Chen
Journal:  Cancer Sci       Date:  2012-02-13       Impact factor: 6.716

2.  Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.

Authors:  Yuk Pheel Park; Seung-Chul Choi; Patricia Kiesler; Aleksandra Gil-Krzewska; Francisco Borrego; Jennifer Weck; Konrad Krzewski; John E Coligan
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

3.  Ran overexpression leads to diminished T cell responses and selectively modulates nuclear levels of c-Jun and c-Fos.

Authors:  Xiaoying Qiao; Diep Ngoc Thi Pham; Hongyu Luo; Jiangping Wu
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

4.  Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells.

Authors:  Andrea Caballero Benitez; Zhenpeng Dai; Henning H Mann; Rebecca S Reeves; Daciana H Margineantu; Ted A Gooley; Veronika Groh; Thomas Spies
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

5.  Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.

Authors:  Shiguo Zhu; Prasad V Phatarpekar; Cecele J Denman; Vladimir V Senyukov; Srinivas S Somanchi; Hoainam T Nguyen-Jackson; Emily M Mace; Alexandra F Freeman; Stephanie S Watowich; Jordan S Orange; Steven M Holland; Dean A Lee
Journal:  Blood       Date:  2014-06-02       Impact factor: 22.113

6.  Functional analysis of differences in transcriptional activity conferred by genetic variants in the 5' flanking region of the IL12RB2 gene.

Authors:  Nahoko Kato-Kogoe; Hideki Ohyama; Soichiro Okano; Koji Yamanegi; Naoko Yamada; Masaki Hata; Hiroshi Nishiura; Yoshimitsu Abiko; Nobuyuki Terada; Keiji Nakasho
Journal:  Immunogenetics       Date:  2015-11-09       Impact factor: 2.846

7.  Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line.

Authors:  Duk Seong Bae; Jae Kwon Lee
Journal:  Blood Res       Date:  2014-09-25

8.  The Antitumor Effect of Xihuang Pill on Treg Cells Decreased in Tumor Microenvironment of 4T1 Breast Tumor-Bearing Mice by PI3K/AKT~AP-1 Signaling Pathway.

Authors:  Xin-Ye Li; Liang Su; Yi-Ming Jiang; Wen-Bin Gao; Chun-Wei Xu; Chang-Qian Zeng; Jie Song; Yu Xu; Wen-Cai Weng; Wen-Bo Liang
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-23       Impact factor: 2.629

9.  ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.

Authors:  Giulio Sartori; Sara Napoli; Luciano Cascione; Elaine Yee Lin Chung; Valdemar Priebe; Alberto Jesus Arribas; Afua Adjeiwaa Mensah; Michela Dall'Angelo; Chiara Falzarano; Laura Barnabei; Mattia Forcato; Andrea Rinaldi; Silvio Bicciato; Margot Thome; Francesco Bertoni
Journal:  J Exp Clin Cancer Res       Date:  2021-11-11

10.  Runx3-mediated transcriptional program in cytotoxic lymphocytes.

Authors:  Joseph Lotem; Ditsa Levanon; Varda Negreanu; Dena Leshkowitz; Gilgi Friedlander; Yoram Groner
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.